Lung cancer is the top cancer killer and smoking remains the leading preventable cause of death in the US. Furthermore, major disparities in smoking and lung cancer exist by education, income, and race/ethnicity. While tobacco control policies are the most effective strategies to prevent lung cancers, lung cancer computed tomography (CT) screening has also been shown to reduce lung cancer risk among heavy current and former smokers. The Cancer Intervention and Surveillance Modeling Network (CISNET) lung group develops and applies population models for lung cancer, quantifying the impact of tobacco control and CT screening on lung cancer and all-cause mortality. To date, this work has focused on the country as a whole and has yet to account for tobacco and lung cancer disparities by subgroup and region. This proposed work will extend existing CISNET lung models to investigate the synergistic impacts of tobacco control policies and lung cancer screening in the US and in middle-income nations, focusing on disparities in both smoking behavior and lung cancer risk. The smoking and lung cancer models will incorporate other factors that reflect different smoking risks such as race/ethnicity, education, income, and geographic location. This will allow for analyses of the effects of tobacco control policies on US smoking prevalence in relevant high-risk groups, and estimation of the impact of policies on health disparities in smoking and lung cancer outcomes. Models will also be adapted for two middle-income nations, Mexico and Thailand, to evaluate the impact of tobacco control policies on smoking and lung cancer rates in middle-income countries with different demographic and smoking behavior profiles than the US. Although lung cancer screening is now supported by the USPSTF and other major national organizations, there is still considerable debate over the potential benefits and harms of screening at the population level. This project will extend CISNET lung cancer screening models to assess the consequences of heterogeneity in lung cancer screening implementation, insurance coverage, and compliance with recommended protocols on population health. Models will also be used to investigate the implications of using alternative individual risk prediction measures as eligibility criteria for screening, and to perfom cost-effectiveness analyses of current and alternative screening recommendations, with the goal of identifying optimal strategies at the population level.

Public Health Relevance

Lung cancer is the top cancer killer and smoking remains the leading preventable cause of death in the US. Furthermore, major disparities in smoking and lung cancer exist by education, income, race/ethnicity, and region. The Cancer Intervention and Surveillance Modeling Network (CISNET) lung group develops and applies population models for lung cancer, quantifying the impact of tobacco control and CT screening on lung cancer and all-cause mortality. This proposed work will extend existing CISNET lung models to investigate the synergistic impacts of tobacco control policies and lung cancer screening in the US and in middle-income nations, focusing on disparities in both smoking behavior and lung cancer risk.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01CA199284-01
Application #
8967752
Study Section
Special Emphasis Panel (ZCA1-PCRB-C (M1))
Program Officer
Scott, Susan M
Project Start
2015-09-16
Project End
2020-08-31
Budget Start
2015-09-16
Budget End
2016-08-31
Support Year
1
Fiscal Year
2015
Total Cost
$1,751,835
Indirect Cost
$220,617
Name
University of Michigan Ann Arbor
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Han, Summer S; Ten Haaf, Kevin; Hazelton, William D et al. (2018) Re: Think before you leap. Int J Cancer 142:1507-1509
Criss, Steven D; Sheehan, Deirdre F; Palazzo, Lauren et al. (2018) Population impact of lung cancer screening in the United States: Projections from a microsimulation model. PLoS Med 15:e1002506
Jeon, Jihyoun; Holford, Theodore R; Levy, David T et al. (2018) Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: A Comparative Modeling Approach. Ann Intern Med 169:684-693
Brouwer, Andrew F; Eisenberg, Marisa C; Meza, Rafael (2018) Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence. Cancer Res 78:3386-3396
Caverly, Tanner J; Cao, Pianpian; Hayward, Rodney A et al. (2018) Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study. Ann Intern Med 169:1-9
Levy, David T; Borland, Ron; Lindblom, Eric N et al. (2018) Potential deaths averted in USA by replacing cigarettes with e-cigarettes. Tob Control 27:18-25
Levy, David T; Tam, Jamie; Kuo, Charlene et al. (2018) The Impact of Implementing Tobacco Control Policies: The 2017 Tobacco Control Policy Scorecard. J Public Health Manag Pract 24:448-457
Levy, David T; Yuan, Zhe; Li, Yameng (2018) The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use. BMC Public Health 18:696
Levy, David T; Yuan, Zhe; Luo, Yuying et al. (2018) The Relationship of E-Cigarette Use to Cigarette Quit Attempts and Cessation: Insights From a Large, Nationally Representative U.S. Survey. Nicotine Tob Res 20:931-939
Tam, Jamie; Levy, David T; Jeon, Jihyoun et al. (2018) Projecting the effects of tobacco control policies in the USA through microsimulation: a study protocol. BMJ Open 8:e019169

Showing the most recent 10 out of 31 publications